An inulin-type fructan CP-A from Codonopsis pilosula attenuates experimental colitis in mice by promoting autophagy-mediated inactivation of NLRP3 inflammasome

Abstract

Inulin-type fructan CP-A, a predominant polysaccharide in Codonopsis pilosula, demonstrates regulatory effects on immune activity and anti-inflammation. The efficacy of CP-A in treating ulcerative colitis (UC) is, however, not well-established. This study employed an in vitro lipopolysaccharide (LPS)-induced colonic epithelial cell model (NCM460) and an in vivo dextran sulfate sodium (DSS)-induced colitis mouse model to explore CP-A’s protective effects against experimental colitis and its underlying mechanisms. We monitored the clinical symptoms in mice using various parameters: body weight, disease activity index (DAI), colon length, spleen weight, and histopathological scores. Additionally, molecular markers were assessed through enzyme-linked immunosorbent assay (ELISA), quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence (IF), immunohistochemistry (IHC), and Western blotting assays. Results showed that CP-A significantly reduced reactive oxygen species (ROS), tumor necrosis factor-alpha (TNF-α), and interleukins (IL-6, IL-1β, IL-18) in LPS-induced cells while increasing IL-4 and IL-10 levels and enhancing the expression of Claudin-1, ZO-1, and occludin proteins in NCM460 cells. Correspondingly, in vivo findings revealed that CP-A administration markedly improved DAI, reduced colon shortening, and decreased the production of myeloperoxidase (MPO), malondialdehyde (MDA), ROS, IL-1β, IL-18, and NOD-like receptor protein 3 (NLRP3) inflammasome-associated genes/proteins in UC mice. CP-A treatment also elevated glutathione (GSH) and superoxide dismutase (SOD) levels, stimulated autophagy (LC3B, P62, Beclin-1, and ATG5), and reinforced Claudin-1 and ZO-1 expression, thereby aiding in intestinal epithelial barrier repair in colitis mice. Notably, the inhibition of autophagy via chloroquine (CQ) diminished CP-A’s protective impact against colitis in vivo. These findings elucidate that CP-A’s therapeutic effect on experimental colitis possibly involves mitigating intestinal inflammation through autophagy-mediated NLRP3 inflammasome inactivation. Consequently, inulin-type fructan CP-A emerges as a promising drug candidate for UC treatment.

Keywords

Inulin-type fructan CP-A / Codonopsis pilosula / Ulcerative colitis / NLRP3 inflammasome / Autophagy

References

[1] Su Q, He J, Wang Z, et al. Intestinal anti-inflammatory effect of the rhizome extracts of Menispermum dauricum DC. on trinitrobenzene sulfonic acid induced ulcerative colitis in mice[J]. J Ethnopharmacol, 2016, 193: 12-20.

[2] Yun J, Xu CT, Pan BR. Epidemiology and gene markers of ulcerative colitis in the Chinese[J]. World J Gastroenterol, 2009, 15(7): 788-803.

[3] Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis[J]. Lancet, 2012, 380(9853): 1606-1619.

[4] Wu N, Du X, Peng Z, et al. Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model[J]. J Int Med Res, 2021, 49(3): 0300060520986313.

[5] Chen G, Yang Y, Liu M, et al. Banxia Xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice[J]. J Ethnopharmacol, 2015, 166: 149-156.

[6] Matsuoka K, Kobayashi T, Ueno F, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease[J]. J Gastroenterol, 2018, 53: 305-353.

[7] Shaker ME, Ashamallah SA, Houssen ME. Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis[J]. Chem Biol Interact, 2014, 210: 26-33.

[8] Wang S, Liu W, Wang J, et al. Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4[J]. Life Sci, 2020, 259: 118356.

[9] Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases[J]. Autophagy, 2020, 16: 3-17.

[10] Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory Bowel disease[J]. Front Immunol, 2019, 10: 276.

[11] Zahid A, Li B, Kombe AJK, et al. Pharmacological inhibitors of the NLRP3 inflammasome[J]. Front Immunol, 2019, 10: 2538.

[12] Atianand MK, Rathinam VA, Fitzgerald KA. SnapShot: inflammasomes[J]. Cell, 2013, 153(1): 272-272 e271.

[13] Darisipudi MN, Allam R, Rupanagudi KV, et al. Polyene macrolide antifungal drugs trigger interleukin-1beta secretion by activating the NLRP3 inflammasome[J]. PLoS One, 2011, 6: e19588.

[14] Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization[J]. Nat Immunol, 2008, 9: 847-856.

[15] Lupfer C, Thomas PG, Anand PK, et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection[J]. Nat Immunol, 2013, 14: 480-488.

[16] Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs[J]. Cell Death Differ, 2015, 22: 377-388.

[17] Carneiro LA, Travassos LH. The interplay between NLRs and autophagy in immunity and inflammation[J]. Front Immunol, 2013, 4: 361.

[18] Oshitani N, Sawa Y, Hara J, et al. Functional and phenotypical activation of leucocytes in inflamed human colonic mucosa[J]. J Gastroen Hepatol 1997, 12( 12): 809-814.

[19] Jie F, Xiao S, Qiao Y, et al. Kuijieling decoction suppresses NLRP3-mediated pyroptosis to alleviate inflammation and experimental colitis in vivo and in vitro[J]. J Ethnopharmacol, 2021, 264: 113243.

[20] Li JK, Wang Y, Ji JJ, et al. Structural characterization and immunomodulatory activity of a glucan from Radix Codonopsis[J]. J Funct Foods, 2021, 83: 104537.

[21] Zou YF, Chen XF, Malterud KE, et al. Structural features and complement fixing activity of polysaccharides from Codonopsis pilosula Nannf. var modesta L.T.Shen roots[J]. Carbohydr Polym, 2014, 113: 420-429.

[22] Guo Y, Shao YY, Zhao YN, et al. Pharmacokinetics, distribution and excretion of inulin-type fructan CPA after oral or intravenous administration to mice[J]. Food Funct, 2022, 13: 4130-4141.

[23] Li J, Wang T, Zhu Z, et al. Structure features and anti-gastric ulcer effects of inulin-type fructan CP-A from the roots of Codonopsis pilosula (Franch.) Nannf[J]. Molecules, 2017, 22(12): 2258

[24] Ding A, Wen X. Dandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitis[J]. J Nat Med, 2018, 72: 857-866.

[25] Zhou J, Wang T, Dou Y, et al. Brusatol ameliorates 2,4,6-trinitrobenzenesulfonic acid-induced experimental colitis in rats: involvement of NF-kappaB pathway and NLRP3 inflammasome[J]. Int Immunopharmacol, 2018, 64: 264-274.

[26] Rukshala D, de Silva ED, Ranaweera B, et al. Anti-inflammatory effect of leaves of Vernonia zeylanica in lipopolysaccharide-stimulated RAW 264.7 macrophages and carrageenan-induced rat paw-edema model[J]. J Ethnopharmacol, 2021, 274: 114030.

[27] Su J, Li C, Yu X, et al. Protective effect of pogostone on 2,4,6-trinitrobenzenesulfonic acid-induced experimental colitis via inhibition of T Helper cell[J]. Front Pharmacol, 2017, 8: 829.

[28] Liu Q, Zuo R, Wang K, et al. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway[J]. Acta Pharmacol Sin, 2020, 41: 771-781.

[29] Zhou J, Tan L, Xie J, et al. Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice[J]. Drug Deliv, 2017, 24: 1667-1679.

[30] Wang J, Zhang C, Guo C, et al. Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora[J]. Int J Mol Sci, 2019, 20(22): 5751.

[31] Wang L, Yu Z, Wei C, et al. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation[J]. Oncotarget, 2017, 8: 32937-32945.

[32] Kahlenberg JM, Lundberg KC, Kertesy SB, et al. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-κB-driven protein synthesis[J]. J Immunol, 2005, 175(11): 7611-7622.

[33] Bai Y, Hou J, Zhang XT, et al. Zanthoxylum bungeanum seed oil elicits autophagy and apoptosis in human laryngeal tumor cells via PI3K/AKT/mTOR signaling pathway[J]. Anti-cancer Agent Me, 2021, 21(18): 2610-2619.

[34] Lv Q, Xing Y, Liu J, et al. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation[J]. Acta Pharm Sin B, 2021, 11(9): 2880-2899.

[35] Wu H, Chen QY, Wang WZ, et al. Compound sophorae decoction enhances intestinal barrier function of dextran sodium sulfate induced colitis via regulating notch signaling pathway in mice[J]. Biomed Pharmacother, 2021, 133: 110937.

[36] Zhang SQ, Ni WK, Xiao MB, et al. Actin related protein 3 (ARP3) promotes apoptosis of intestinal epithelial cells in ulcerative colitis[J]. Pathol Res Pract, 2019, 215(2): 235-242.

[37] Hou J, Wang J, Meng J, et al. Zanthoxylum bungeanum seed oil attenuates LPS-induced BEAS-2B cell activation and inflammation by inhibiting the TLR4/MyD88/NF-κB signaling pathway[J]. Evid-Based Compl Alt, 2021, 2021: 2073296.

[38] Peng Y, Li H, Chen D. Silencing astrocyte elevated gene-1 attenuates lipopolysaccharide-induced inflammation and mucosal barrier injury in NCM460 cells by suppressing the activation of NLRP3 inflammasome[J]. Cell Biol Int, 2019, 43(1): 56-64.

[39] Kim JJ, Shajib MS, Manocha MM, et al. Investigating intestinal inflammation in DSS-induced model of IBD[J]. J Vis Exp, 2012, (60): 3678.

[40] Jeon YD, Lee JH, Lee YM, et al. Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model[J]. Biomed Pharmacother, 2020, 124: 109847.

[41] Aratani Y. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function[J]. Arch Biochem Biophys, 2018, 640: 47-52.

[42] Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis[J]. Nat Rev Immunol, 2014, 14: 141-153.

[43] Khan I, Ullah N, Zha L, et al. Alteration of gut microbiota in inflammatory Bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome[J]. Pathogens, 2019, 8(3): 126.

[44] Vindigni SM, Zisman TL, Suskind DL, et al. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions[J]. Therap Adv Gastroenterol, 2016, 9: 606-625.

[45] Lechuga S, Ivanov AI. Disruption of the epithelial barrier during intestinal inflammation: quest for new molecules and mechanisms[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864(7): 1183-1194.

[46] Pan HH, Zhou XX, Ma YY, et al. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy[J]. World J Gastroenterol, 2020, 26(33): 4945-4959.

[47] Nighot PK, Hu CA, Ma TY. Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation[J]. J Biol Chem, 2015, 290(11): 7234-7246.

[48] Zhang H, Lang W, Liu X, et al. Procyanidin A1 alleviates DSS-induced ulcerative colitisvia regulating AMPK/mTOR/p70S6K-mediated autophagy[J]. J Physiol Biochem, 2022, 78: 213-227.

[49] Su S, Wang X, Xi X, et al. Phellodendrine promotes autophagy by regulating the AMPK/mTOR pathway and treats ulcerative colitis[J]. J Cell Mol Med, 2021, 25(12): 5707-5720.

[50] Wang Y, Li YB, Yin JJ, et al. Autophagy regulates inflammation following oxidative injury in diabetes[J]. Autophagy, 2013, 9: 272-277.

[51] Zhang Y, Liu G, Dull RO, et al. Autophagy in pulmonary macrophages mediates lung inflammatory injury via NLRP3 inflammasome activation during mechanical ventilation[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 307(2): L173-L185.

[52] Ornatowski W, Lu Q, Yegambaram M, et al. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease[J]. Redox Biol, 2020, 36: 101679.

[53] Kim KH, Lee MS. Autophagy-a key player in cellular and body metabolism[J]. Nat Rev Endocrinol, 2014, 10: 322-337.

[54] Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation[J]. Antioxid Redox Signal, 2014, 20(3): 460-473.

[55] Yang M, Zhang F, Yang C, et al. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer[J]. J Crohns Colitis, 2020, 14(1): 130-141.

[56] Zhou Y, Yang M, Yan X, et al. Oral nanotherapeutics of andrographolide/carbon monoxide donor for synergistically anti-inflammatory and pro-resolving treatment of ulcerative colitis[J]. ACS Appl Mater Interfaces, 2023, 15(30): 36061-36075.

[57] Yan X, Meng L, Zhang X, et al. Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses[J]. Mol Ther, 2023, 31(5): 1383-1401.

[58] Ma YA, Zhao JJ, Cheng LL, et al. Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics[J]. Carbon, 2023, 204: 526-537.

[59] Pavillard LE, Canadas-Lozano D, Alcocer-Gomez E, et al. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction[J]. Oncotarget, 2017, 8: 99740-99756.

[60] Chiu HW, Chen CH, Chang JN, et al. Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy[J]. J Mol Med (Berl), 2016, 94: 809-819.

[61] Dai J, Zhang X, Li L, et al. Autophagy inhibition contributes to ROS-producing NLRP3-dependent inflammasome activation and cytokine secretion in high glucose-induced macro- phages[J]. Cell Physiol Biochem, 2017, 43(1): 247-256.

Funding

National Natural Science Foundation of China(81904031)

National Key Research and Development Program of China(2019YFC1710800)

Natural Science Foundation of Shanxi Province(201901D211325)

Science Research Start-up Fund for Doctor of Shanxi Medical University(XD1802)